105 related articles for article (PubMed ID: 20136718)
1. Lactoferrin protects against concanavalin A-induced liver injury in mice.
Yin H; Cheng L; Agarwal C; Agarwal R; Ju C
Liver Int; 2010 Apr; 30(4):623-32. PubMed ID: 20136718
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
Li B; Sun R; Wei H; Gao B; Tian Z
Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
[TBL] [Abstract][Full Text] [Related]
5. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
6. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
[TBL] [Abstract][Full Text] [Related]
7. Paeoniflorin protects against concanavalin A-induced hepatitis in mice.
Chen M; Cao L; Luo Y; Feng X; Sun L; Wen M; Peng S
Int Immunopharmacol; 2015 Jan; 24(1):42-9. PubMed ID: 25479726
[TBL] [Abstract][Full Text] [Related]
8. CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10.
Xu C; Zhang C; Ji J; Wang C; Yang J; Geng B; Zhao T; Zhou H; Mu X; Pan J; Hu S; Lv Y; Chen X; Wen H; You Q
Hepatology; 2018 May; 67(5):1943-1955. PubMed ID: 29220536
[TBL] [Abstract][Full Text] [Related]
9. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
[TBL] [Abstract][Full Text] [Related]
10. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease.
Lee KC; Lin HC; Huang YH; Hung SC
J Hepatol; 2015 Dec; 63(6):1405-12. PubMed ID: 26276675
[TBL] [Abstract][Full Text] [Related]
11. CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.
Chen Y; Peng H; Chen Y; Wei H; Sun R; Tian Z
Immunology; 2014 Mar; 141(3):388-400. PubMed ID: 24164540
[TBL] [Abstract][Full Text] [Related]
12. Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions.
Wan J; Zhu YN; Feng JQ; Chen HJ; Zhang RJ; Ni J; Chen ZH; Hou LF; Liu QF; Zhang J; Yang L; Tang W; Yang YF; Nan FJ; Zhao WM; Zuo JP
Int Immunopharmacol; 2008 Sep; 8(9):1248-56. PubMed ID: 18602071
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice.
Volarevic V; Milovanovic M; Ljujic B; Pejnovic N; Arsenijevic N; Nilsson U; Leffler H; Lukic ML
Hepatology; 2012 Jun; 55(6):1954-64. PubMed ID: 22213244
[TBL] [Abstract][Full Text] [Related]
14. CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice.
Zhang H; Gong Q; Li JH; Kong XL; Tian L; Duan LH; Tong J; Song FF; Fang M; Zheng F; Xiong P; Tan Z; Gong FL
Int Immunopharmacol; 2010 Jan; 10(1):79-85. PubMed ID: 19818415
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin protects against acetaminophen-induced liver injury in mice.
Yin H; Cheng L; Holt M; Hail N; Maclaren R; Ju C
Hepatology; 2010 Mar; 51(3):1007-16. PubMed ID: 20099297
[TBL] [Abstract][Full Text] [Related]
16. A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in mice.
Fan K; Zhang B; Yang H; Wang H; Tan M; Hou S; Qian W; Li B; Wang H; Dai J; Guo Y
Eur J Pharmacol; 2011 Apr; 657(1-3):144-51. PubMed ID: 21300057
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of galangin in Concanavalin A-induced hepatitis in mice.
Luo Q; Zhu L; Ding J; Zhuang X; Xu L; Chen F
Drug Des Devel Ther; 2015; 9():2983-92. PubMed ID: 26089647
[TBL] [Abstract][Full Text] [Related]
18. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
Kremer M; Hines IN; Milton RJ; Wheeler MD
Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
[TBL] [Abstract][Full Text] [Related]
19. Active ingredients of traditional Japanese (kampo) medicine, inchinkoto, in murine concanavalin A-induced hepatitis.
Mase A; Makino B; Tsuchiya N; Yamamoto M; Kase Y; Takeda S; Hasegawa T
J Ethnopharmacol; 2010 Feb; 127(3):742-9. PubMed ID: 19962433
[TBL] [Abstract][Full Text] [Related]
20. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice.
Louis H; Le Moine O; Peny MO; Quertinmont E; Fokan D; Goldman M; Devière J
Hepatology; 1997 Jun; 25(6):1382-9. PubMed ID: 9185757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
